Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
464.24
+5.02 (1.09%)
At close: Sep 26, 2025, 4:00 PM EDT
464.44
+0.20 (0.04%)
After-hours: Sep 26, 2025, 7:00 PM EDT
Thermo Fisher Market Cap
Thermo Fisher has a market cap or net worth of $175.30 billion as of September 26, 2025. Its market cap has decreased by -25.80% in one year.
Market Cap
175.30B
Enterprise Value
204.14B
1-Year Change
-25.80%
Ranking
Category
Stock Price
$464.24
Market Cap Chart
Since December 1, 1998, Thermo Fisher's market cap has increased from $2.71B to $175.30B, an increase of 6,369.45%. That is a compound annual growth rate of 16.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 175.30B | -11.90% |
| Dec 31, 2024 | 198.99B | -2.97% |
| Dec 29, 2023 | 205.08B | -5.04% |
| Dec 30, 2022 | 215.98B | -17.86% |
| Dec 31, 2021 | 262.92B | 42.43% |
| Dec 31, 2020 | 184.61B | 41.71% |
| Dec 31, 2019 | 130.27B | 44.60% |
| Dec 31, 2018 | 90.09B | 18.32% |
| Dec 29, 2017 | 76.14B | 36.60% |
| Dec 30, 2016 | 55.74B | -1.54% |
| Dec 31, 2015 | 56.61B | 12.95% |
| Dec 31, 2014 | 50.12B | 24.56% |
| Dec 31, 2013 | 40.24B | 75.14% |
| Dec 31, 2012 | 22.97B | 35.05% |
| Dec 30, 2011 | 17.01B | -22.69% |
| Dec 31, 2010 | 22.00B | 13.00% |
| Dec 31, 2009 | 19.47B | 36.01% |
| Dec 31, 2008 | 14.32B | -40.91% |
| Dec 31, 2007 | 24.23B | 238.55% |
| Dec 29, 2006 | 7.16B | 46.40% |
| Dec 30, 2005 | 4.89B | 1.23% |
| Dec 31, 2004 | 4.83B | 17.69% |
| Dec 31, 2003 | 4.10B | 24.71% |
| Dec 31, 2002 | 3.29B | -22.44% |
| Dec 31, 2001 | 4.24B | -20.79% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |